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Objective. Strength training is recommended for people with hemophilia; 
however, published data are anecdotal and have methodological limitations. 
The purpose of this study was to evaluate safety and effectiveness of 
progressive moderate-to-vigorous intensity elastic resistance training on 
physical function and pain in this patient population.  
Methods. A randomized controlled trial was conducted in a university laboratory 
setting, where 20 patients (17 with severe, 1 with moderate, and 2 with mild 
hemophilia) who were aged 21 to 53 years received evaluations at baseline and 
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strength training) or control (usual daily activities) groups. The intervention 
group trained 2 days per week during 8 weeks with elastic resistance. Intensity 
during the first 2 weeks was a 20-repetition maximum (RM) and increased 
progressively toward 15RM, 12RM, and finally 10RM. The primary outcome was 
muscle strength. Secondary outcomes were: Timed “Up and Go” Test (TUG), 
sit-to-stand, ROM, Haemophilia Joint Health Score (HJHS), kinesiophobia 
score, global impression of pain change, general self-rated health status, and 
desire to exercise.   
Results. The intervention group showed greater strength improvements than 
the control group in almost all of the joints, with moderate to high effect sizes. 
The intervention group also showed better TUG and sit-to-stand scores than the 
control group (moderate effect size), greater ROM at the knee flexion with the 
right leg (trivial effect size), and better HJHS at the left knee (small effect size). 
The intervention group showed greater overall pain reduction, self-rated overall 
status, and desire to exercise than the control group. 
Conclusions. Progressive strength training with elastic resistance performed 
twice a week during 8 weeks is safe and effective in people with hemophilia to 
improve muscle strength and functional capacity, reduce general pain, and 
improve self-rated health status and desire to exercise.  
Impact. This study provides evidence for the use of a specific strength training 
regimen for people with hemophilia. 
Lay summary. People with hemophilia of differing levels of severity, with 
adequate coverage with clotting factor, can safely engage in progressive 
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Hemophilia is a hereditary bleeding disorder caused by deficiencies in coagulation 
factors VIII (hemophilia A) and IX (hemophilia B).1 This disease produces spontaneous 
bleeding episodes, especially at intra-articular level,2 initiating a vicious cycle of pain,3 
physical inactivity, muscle weakness, muscle atrophy and increased bleeding risk.4 In 
consequence, synovitis and cartilage and bone deterioration occur5 leading to joint 
disease in 90% of people with severe hemophilia.6  
Avoided in the past, physical exercise is now recommended in people with hemophilia 
with adequate coverage factor. Among different types of exercise, strength training is 
advised to recover physical function in those with chronic arthropathy,7 becoming 
more important with age8 and arthropathy severity.9 Strength training can decrease 
the number of circulating inflammatory cells, reducing or preventing bleedings and 
associated pain.10  
Although recent reviews7 and expert opinions11 highlighted the relevance of strength 
training for people with hemophilia, published data remains anecdotal and with 
methodological limitations. Thus, it remains unclear whether strength training can 
improve physical function and reduce pain among adult people with hemophilia. 
Several previous studies lacked clear reporting of exercise dosing and progression, and 
when reported, low intensities and volume usually prevail. As with dosing of medicine, 
sufficient exercise volume (ie, quantity) and intensity (ie, magnitude of the dose) are 
needed to induce proper morphological and neural adaptations.12 While low 
intensities (eg, 30% of one-repetition maximum) can improve muscular endurance or 
even maximal strength gains in untrained individuals, higher intensities (eg, 80% of 
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adaptations.13 In the same vein, to induce muscle hypertrophy with low intensities, 
repetitions need to be performed with sufficient fatigue (ie, until muscle failure or near 
muscle failure) to stimulate the motor units with highest threshold14 and enhance 
skeletal muscle protein synthesis.15  
In previous studies, it is plausible that fear of producing bleedings and pain hindered 
investigations on high-intensity strength training among people with hemophilia. 
However, with inclusion of adequate coverage factor, strength training studies are 
needed to find more optimal dosing in terms of effectiveness and safety. In this sense, 
progressive strength training, which has showed effectiveness in treating other 
musculoskeletal conditions16 could be optimal in people with hemophilia due to the 
gradual intensity increase. In addition, besides careful supervision and a correct 
exercise technique, equipment can be a relevant choice to minimize injury risk in  
people with hemophilia. Exercise programs based on elastic resistance bands are 
especially interesting due to minimal impact forces and low risk of accidents compared 
with traditional heavy weights.17 However, there are no studies applying progressive 
moderate-vigorous intensity strength training with elastic resistance in  people with 
hemophilia.  
The purpose of the present study was to evaluate safety and effectiveness of 
progressive moderate-vigorous elastic resistance training on physical function and pain 
in people with hemophilia. We hypothesized that the program would be safe and 
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The present study was a randomized controlled trial with two parallel groups. Subjects 
between 18-60 years old, diagnosed with Hemophilia and visiting a local hospital 
(University and Polytechnic Hospital La Fe, Valencia, Spain) due to an appointment at 
the Haemostasis and Thrombosis Unit during 2017 were candidates for the present 
study and invited to participate. Key inclusion criteria were: 1) diagnosis of mild, 
moderate or severe Hemophilia A or B; 2) severe subjects receiving prophylactic 
treatment; 3) willingness to exercise twice a week during the training program and to 
complete the pre- and post-program evaluations; 3) approval by their hematologist to 
participate in the exercise program; 4) informed consent signed. Key exclusion criteria 
were: 1) the inability to attend exercise sessions at least twice a week for 8 
consecutive weeks; 2) non-adherence to instruction on proper exercise technique; 3) 
joint replacement in the previous year or surgical procedures performed 6 weeks prior 
to or during the exercise program; 4) participation in any other form of programed 
strength exercise during the intervention period; 5) changes in medication during the 
study; and 6) joint or muscle bleeding in the last 3 months; 7) detectable FVIII 
inhibitors at screening (titer ≥ 0.4 Bethesda unit); 8) another hemostatic defect; 9) 
need for major surgery (10), or withdrawal of informed consent. 
All participants were informed about the purpose and content of the project and gave 
their written informed consent to participate in the study. All procedures described in 
this section were approved by the institution’s review board (H1461147538087) and 
comply with the requirements listed in the 1975 Declaration of Helsinki and its 
amendment in 2008. The study was registered in ClinicalTrials.gov (NCT02781233) and 
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[H2] Randomization and allocation 
After receiving a list with possible subjects from a medical doctor (neither involved in 
the testing nor training sessions), the main researcher involved in the recruitment 
process approached the participants, explained them about the study, and asked if 
they would be willing to participate. Those agreeing (20 subjects), were randomly 
allocated following simple randomization procedures (computerized random 
numbers), with an allocation ratio of 1:1 to either an intervention group (progressive 
training) or control (usual daily activities). This allocation process was performed by a 
person who was not involved in the testing and training sessions, and did not have 
access to the results of these test and training data.  
[H2] Intervention 
The intervention consisted of a group-based training program for two days per week 
for a total of 8 weeks, especially focused on increasing muscle strength in the knee-, 
elbow- and ankle-joints (Figure). Table 1 shows the complete intervention training 
program. Sessions were performed at the same time of the day at the university and 
were separated by 72hours. The severe subjects had their prophylactic treatment 1-26 
hours before each training session. Sessions took place under the supervision of two 
physical therapists and a sport scientist and Strength & Conditioning Specialist.  
[H2] Control group 
The control group performed usual daily activities during 8 weeks. During the study 
period, all the participants were asked to maintain their normal diet and usual exercise 
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[H2] Outcome measures 
The following variables were collected from the medical record by a secondary person: 
age, type and severity of hemophilia, prophylaxis regimen (weekly coagulation factor 
dose), Annual Bleeding Joint Rate (ie, bleeding episodes during the last 12 months, 
before starting the study) and degree of hemophilic arthropathy measured 
radiologically with the Pettersson score. This scale evaluates the different elements of 
the articular alteration using an additive score of 0-13 per joint, being 0 the normality 
and 13, maximum joint alteration.18 Pharmacokinetics were determined using Bayesian 
post hoc estimation of individualized pharmacokinetics values (half-life (t1/2), peak 
level and level at training session), obtained using the Web Accessible Population 
Pharmacokinetic Service for Hemophilia (WAPPS-Hemo tool).19 
Participants were scheduled for two testing days, baseline and after eight weeks. All 
measurements were performed at the university by the same two physical therapists, 
who had previous experience with the tests, were blinded to group allocation and 
were not involved in the training supervision to avoid possible risk of bias. 
During baseline testing, height (IP0955, Invicta Plastics Limited, Leicester, England) and 
weight (Tanita model BF- 350, Tokyo, Japan) were firstly recorded as descriptive data. 
In addition, the following variables were assessed at baseline and after the 
intervention: the primary outcome was between-group difference in muscle strength 
gains. Isometric knee flexion and extension, isometric ankle plantarflexion and 
dorsiflexion and isometric elbow flexion and extension were assessed with a portable 
hand-held dynamometer (Nicholas Manual Muscle Tester, Lafayette Instruments, 
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since are the most affected in  people with hemophilia.1 These Specifically, for the 
knee extension and flexion, subjects were seated with back support, with knee angle 
of 70° and hip angle of 110°. For measuring the isometric knee extension strength, the 
dynamometer was positioned perpendicular to the axis of the tibia, proximal to the 
ankle, and fixated by a belt anchored to a handlebar. For measuring the isometric knee 
flexion strength, the dynamometer was placed on the posterior aspect of the lower 
leg, and fixated by a belt anchored to a handlebar. Hand-held dynamometer testing 
has shown good-excellent intra-rater reliability for knee flexors, with an intraclass 
correlation coefficient (ICC) range of 0.76-0.94 and excellent (ICC range of 0.92-0.97) 
for knee extensors.20 For ankle dorsiflexion and plantarflexion, subjects were 
positioned in long sitting (hips flexed and knees extended), with a backrest and the 
ankle in a neutral position according to a previous standardized procedure that 
demonstrated high reliability, with ICCs ranging from 0.88 to 0.90 and 0.94 to 0.96 
respectively.21 For ankle plantarflexion, the dynamometer was fixated with a belt 
anchored to a wall bar and positioned against the plantar surface of the foot, just 
proximal to the metatarsal heads; and for ankle dorsiflexion, against the dorsal surface 
of the foot, just proximal to the metatarsal heads. For the elbow flexion and extension 
tests, subjects were with elbows at 90° in a seated position with erect posture, no back 
support and with both feet placed flat on the floor, with force being exerted against a 
fixed table. Isometric elbow flexion and extension strength tests with the hand-held 
dynamometer have demonstrated good-excellent reliability, with ICCs of 0.87 and 
0.88-0.92, respectively.22  
Passive ROM was measured at the aforementioned joints, with a universal goniometer 
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accordance with the Haemophlia Joint Health Score 2.1 (HJHS 2.1) recommendations. 
The HJHS and the Tampa Scale for kinesiophobia (TSK-11) were used to evaluate joint 
health and fear of movement beliefs respectively, with higher scores reflecting worse 
condition. Both measures have shown high test-retest reliability values, with an ICC of 
0.89 for the HJHS23 and a Cronbach’s α of 0.80 for the TSK-11 total score.24 
The Timed Up and Go (TUG) and the sit-to-stand test were used to measure functional 
capacity.25 The TUG measures the time that a person takes to rise from a standard 
armchair (not using their arms to stand up), walk to a line on the floor 3 m away, turn 
around, walk back to the chair and sit down again. The TUG has excellent intrarater 
reliability, with an ICC of 0.94.26 The sit-to-stand test measures the time taken to stand 
up and sit down from a standard chair with arms three times, as quickly as possible.27 
The sit-to-stand test has demonstrated excellent intrarater reliability, with an ICC of 
0.89.28 In both functional capacity tests, the time is measured in seconds with a 
chronometer, with shorter times indicating better performance. The highest value of 2 
trials for each of these tests was used for the analysis.  
In addition, the following perceived changes were assessed only after the intervention: 
the patient global impression of pain change was evaluated by asking the following 
question: ‘‘Since the start of the study, my overall pain status is”: 1) very much 
improved, 2) much improved, 3) minimally improved, 4) no change, 5) minimally 
worse, 6) much worse, and 7) very much worse. The patient global impression of 
change is a valid tool and represents a true meaningful change to the person,29 being 
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participant characteristics like gender or age.30 A previous study found high test-retest 
reliability when using a global rating of change scale, with an ICC of 0.90.31 
Finally, general health status and desire of practicing exercise were evaluated on a 3-
point scale of “worsened”, “unchanged”, or “improved”. Finally, participants were 
asked to inform if any adverse event occurred during the duration of the study 
(bleedings, pain exacerbation). Similar three-point scales have been traditionally used 
to self-rate health status or other outcomes32,33 and have showed a good reliability, 
with a coefficient of 0.89.34 
[H2] Sample size 
An a priori power analysis was conducted in G*Power (3.1.9.2 version) software to 
calculate the required sample size, using a previous research as reference. In the study 
of Mulvany et al,35 a medium effect size (d=0.7) was obtained in the isometric knee 
strength outcome. Therefore, with the present study design, accepting a 5% alpha risk 
(α=0.05) and 20% beta risk (β=0.2; power=0.80), a total of 20 subjects were required to 
detect at least a medium effect size (f=0.35; d=0.7).  
[H2] Statistical analyses 
Descriptive data of subjects at baseline were compared using the unpaired t test. The 
change-score from baseline to follow-up between intervention and control were 
evaluated using linear mixed models (Proc Mixed, SAS version 9.4) according to the 
intention-to-treat principle. Subject was entered as random effect and fixed effects 
were 1) group, 2) the baseline value of the outcome variable. The estimation method 
was restricted maximum likelihood with degrees of freedom based on the Satterwaite 
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follow-up and between-group differences from baseline to follow-up, with the latter 
being the comparison between control and intervention. Changes were controlled for 
the baseline value of the outcome as a covariant. The covariance structure was set to 
variance component. P-values less than 0.05 were accepted as statistically significant.     
Effect size (Cohen´s d) was calculated and described as: <0.2= trivial effect; 0.2= small; 
0.5= moderate; 0.8= large. Minimal clinically important differences were calculated 
according to previous recommendations36 by multiplying pooled baseline standard 
deviation scores by 0.2.  
[H2] ROLE OF THE FUNDING SOURCE: The funders played no role in the 
design, conduct, or reporting of the study. 
 
[H1] Results 
The Supplementary Figure shows the complete flow chart diagram of the study 
progress. Table 2 shows complete demographic and descriptive data. Participants had 
no previous experience with elastic resistance training.   
The severe subject with daily prophylactic factor had a coverage level at training time 
of 37.8 IU/dL. The mild subject had a coverage level at training time of 11.0 IU/dL 
(basal level). The other subjects at the intervention group had a coverage level at 
training time during the first weekly session of 58.0 (SD 17.2) IU/dL, while at the 
second weekly session they had a coverage level of 10.0 (SD 4.6) IU/dL.  
All subjects attended all the sessions. Tables 3 and 4 show primary and secondary 
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reported. At follow-up, the intervention group showed greater muscle strength in 
almost all the joints (moderate-high effect sizes) and better TUG and sit-to-stand 
(moderate effect size) than controls. In addition, the intervention group showed 
greater ROM at the knee flexion with the right leg (trivial effect size) and better HJHS 
at the left knee (small effect size) at follow-up. All the significant between-group 
differences at follow-up were clinically important, except at the HJHS and ROM. 
Table 5 shows complete perceived changes data. The intervention group showed a 
significantly greater overall pain reduction (p=0.037), self-rated overall status 
(p<0.001) and desire to exercise (p<0.001) than the control group.  
[H1] Discussion 
The main findings of the present study are the safety and effectiveness of progressive 
strength training in improving physical function and reducing general pain in  people 
with hemophilia.  
The high exercise intensity and volume used in the current study likely explain the 
strength gains achieved by the intervention group. These adaptations occurred in spite 
of a relatively low training frequency. With the duration of our program, muscle 
strength gains are primarily mediated by adaptations in motor unit recruitment and 
rate coding37 and secondarily by muscle hypertrophy. In fact, changes in muscle size 
and fascicle angle (which could be reduced due to a arthropathy) are moderately 
associated with isometric strength improvements.38 Besides these anatomical and 
neuromuscular factors, many other factors exist that can influence strength gains after 
a training program. In fact, a very large variation (from −8 to 60%) has been observed 
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Interestingly, the influence of age in strength gains remains less clear and seems to be 
muscle-dependent. For instance, while the previous study found that age did not affect 
strength gains,39 another recent study40 found that average plantarflexion strength 
gains changed little with increased age in healthy individuals. By contrast, dorsiflexion 
strength was more affected by this factor, with an absence of strength gains among 
elderly subjects. Interestingly, dorsiflexion strength was the least affected strength test 
after our intervention. We only found two cases where muscle strength was only 
increased in one side (knee flexion left and elbow flexion right). While a study found 
that limb dominance may provide greater elbow and knee muscle strength in healthy 
young subjects,41 more recent studies have found disparity when using other muscles42 
or among females.43 Another more relevant factor influencing strength gains in people 
with hemophilia could be the joint health status, since a worse condition is associated 
with a weaker extremity.44 Thus, it is plausible that those having a greater degree of 
hemophilic arthropathy would have a reduced baseline strength performance, having 
a greater window of opportunity for improving. However, no previous studies exist 
aiming at explaining the influence of such factors on strength changes after an 
intervention in people with hemophilia. Thus, future studies investigating this should 
be conducted.  
The intervention group showed greater strength improvements than controls in almost 
all the measured joints, with especially remarkable changes at the knee extension. In 
contrast, a previous study in people with hemophilia found no quadriceps strength 
improvements after a walking, balance and low intensity strength training performed 
5-7 days/week during 4 months.45 However, in line with our results, other studies in 
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stretching, cardiovascular and strength training,35 6 months of proprioceptive and low 
intensity strength training46 or a 6-month mobility, coordination, strength and 
endurance training.47 In previous studies, the absence of control group35 or the use of 
participants without Hemophilia as controls46 are clear limitations. Interestingly, two of 
these studies included elastic resistance, albeit intensity prescription was based on the 
colors of the band35 or was not reported,46 hindering comparison across studies and 
proper individualized dosing.  
Regarding the secondary outcomes, TUG and sit-to-stand showed greater 
improvements in the intervention group, with a moderate effect size. A previous study 
found that walking performance in boys with Hemophilia may depend on knee 
extensor strength.48 In the same vein, knee extensor strength has been highlighted as 
the key determinant of TUG in subjects with knee osteoarthritis.49 Supporting this 
notion, a previous program in people with hemophilia45 that failed in improving knee 
extensor strength did not find changes at the TUG, sit-to-stand test and also at gait 
speed test while other studies reporting muscle strength gains showed greater walking 
performance.35,47  
ROM only significantly improved after the intervention in the knee flexion with the 
right leg, although with a non-clinically relevant difference. Interestingly, ROM at the 
knee flexion with the left leg and the elbow flexion with the right arm showed a 
borderline significant result favoring the intervention group, with a small effect size 
and clinically important differences. A previous non-controlled trial35 including 
prolonged flexibility and strength exercises did increase knee, ankle and elbow ROM. 
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greater ROM gains, our findings are somehow positive, showing some improvement 
after only performing strength training. ROM results could be influenced by muscle 
strength gains50 or pain reduction. Finally, a relatively small opportunity window for 
ROM improvement must be considered due to the arthropathy degree of some 
subjects, as Petersson scores reflect, especially in ankles, with average values of 6.1 
and 5.9 in right and left ankle, respectively, in the intervention group. 
Joint health measured with the HJHS improved in the left knee after the intervention 
and this probably caused a borderline significant result at the total score favoring this 
group, with a small effect size and a clinically relevant difference. Unfortunately, no 
longitudinal studies evaluated responsiveness of the HJHS and its sensitivity for 
assessing progression in adult subjects with more severe joint damage is likely 
limited.51 However, this test is associated with bleeding rates and physician global 
assessment of joint health51 so our results for this outcome could have clinical 
implications.  
The intervention group showed greater overall pain reduction and self-rated overall 
health status after finishing the study than the control group. Importantly, 70% of our 
participants reported a clinically important pain change, defined in a previous study30 
as ‘much improved’ or ‘very much improved’, which related to approximately 30% pain 
reduction regardless of study, disease type, age, sex, study result, or treatment group. 
Together with the high prevalence of constrains to perform daily life activities due to 
pain in adult people with hemophilia,52 our results seem relevant. A mechanism 
explaining the improvement of this outcome is the release of peripheral and central 
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pain reduction after an educational physiotherapy program that included home-based 
low-intensity isometric exercise,54 after a home-based body weight strength and 
balance training55 or after mobility, coordination, strength and endurance training.56 
However, the later study56 found an improved general health perception after the 
program, in line with our results. Both the overall pain and physical function changes in 
the intervention group could have mediated the improved self-reported health status.  
The intervention group increased the desire of practicing exercise after the program, 
while 90% of controls did not change. This psychological benefit may be caused by the 
general positive effects of the program and could explain its high adherence. Despite 
no other similar studies explored this outcome in people with hemophilia, a previous 
strength training program32 demonstrated improving the desire to exercise in most of 
the participants when the program was group-based and supervised. Proper guidance 
and keeping in touch with others peers are key elements to participate in weekly 
group-based programs.57 This could also be more relevant in people with hemophilia 
due to their possible safety concerns about strength training.  
A novel and relevant finding is that people with hemophilia in the intervention group 
tolerated a strength training program with higher intensities and volume than 
previously reported in the literature, without any bleeding or other adverse event, or 
without increased fear of movement. An expert consensus statement recommended 
that plasma factor level should be between 15 to 30% when intensive sport activity is 
carried out.58 However, most of the severe subjects in our intervention group (90% of 
participants) were below these levels during the second weekly session. Specifically, 






/ptj/advance-article-abstract/doi/10.1093/ptj/pzaa106/5855483 by Aalborg U


















coverage of factor VIII lower than 15% -although near. Some factors that could explain 
the safety of our program are the close supervision, progressive intensity without 
reaching muscle failure and exercises performed with controlled speed. In fact, we 
have previously showed the general good tolerability and safety of some of these 
exercises when performed in a single session.59,60 In addition, the term “intensive” 
needs to be better defined since depend on many factors. Interestingly, weight-
training sports have demonstrated relatively low injury rates compared with common 
team sports.61 It seems that when performed with adequate coverage factor, strength 
training of sufficient high intensity and volume can be safely performed to achieve 
positive physiological adaptations. To our knowledge, this is the first study providing 
specific factor coverage data during a strength training intervention. Future studies 
should make an attempt to provide this data so exercise prescription in this population 
can be improved.  
An increased kinesiophobia in people with hemophilia would affect adherence and 
initiates a vicious cycle of physical inactivity to avoid pain, increasing muscle weakness, 
disability and depression probability,62 which in turn leads to chronic pain and greater 
bleeding risk63 likely accelerating arthropathy severity. It is plausible that the low levels 
of kinesiophobia showed by our participants before starting the study explain the 
absence of reduction. In addition, multidisciplinary programs combining physical 
training and education seem more effective in reducing kinesiophobia, at least in 
subjects with chronic pain.64 Unfortunately, no other intervention studies have 
evaluated kinesiophobia changes in  people with hemophilia. 
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The generalizability of our results could be improved with a larger sample size. 
However, the number of participants was sufficient in accordance with an a priori 
power analysis. Since neuromuscular adaptations have a training-specific component, 
a possible limitation of our study is that dynamic muscle strength rather than isometric 
assessment could have provided further differences. However, isometric assessments 
with a hand-held dynamometer are valid and reliable.  
Together with the novelty, the exercise dosing and clear reporting of our program are 
major strengths of the current study. A more detailed documentation of training 
protocols is needed in future studies, allowing subjects and researchers understanding 
what was done and what caused the specific results.  
[H1] Conclusions 
Progressive moderate-vigorous intensity strength training with elastic resistance 
performed twice a week during 8 weeks is safe and effective in people with hemophilia 
to improve muscle strength and functional capacity, reduce general pain and improve 
self-rated health status and desire to exercise.  
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Table 1. Intervention Training Program.
a 
a
RM = repetition maximum; ROM = range of motion.
Frequency 2 days per week during 8 weeks. 
Exercises Knee extension, knee flexion, ankle plantarflexion, ankle dorsal flexion, elbow 
flexion, elbow extension, shoulder abduction and hip abduction, all performed 
with full range of motion (ROM) and with elastic bands (TheraBand CLX, The 
Hygenic Corporation, Akron, OH, USA). 
Exercise order   In each session, the exercises were performed in a different order and in a 
rotation manner, switching from one exercise to the next so that the muscles 
were fatigued alternately.  
Warm-up  A warm-up set was performed before each specific exercise by using a light 
resistance to easily perform 10 repetitions without fatigue. 
Volume 3 sets of each exercise. The number of reps decreased as intensity increased.  
Rest 1 minute between sets and exercises. 
Intensity Intensity progressively increased to gradually augment the stimulation during 
the intervention, starting with a moderate intensity of 20 repetition maximum 
(RM) and increasing each two weeks towards high intensities of 15RM, 12RM 
and finally 10RM. Subjects were asked to complete the targeted number of 
repetitions (eg, 20) with an elastic tension that would allow performing an 
additional repetition (eg, 21) once they stopped the exercise -that is, finishing 
the set staying one repetition below muscle failure. To achieve adequate 
exercise intensity during each exercise, the elastic bands were pre stretched to 
approx. 50% of the initial length (initial length, 1.9 m) and then different bands 
were added when needed to reach the desirable intensity. With this purpose, 
red, blue, black, silver and gold elastic band colors were allowed, alone or in 
combination. 
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Table 2. Descriptive Data of Subjects at Baseline.
a 
 
  Control (n = 10) 
Intervention 
(n = 10) 
P (95% CI)  
  Mean SD Mean SD  
Demographics and pharmacokinetics 
    
 
Age (years) 39.1 8.4 36.3 10.5 .52 (-11.76 to 6.16) 
Height (cm) 174.3 7.6 172.8 7.9 .67 (-8.80 to 5.80) 
Body mass (Kg) 83.1 27.5 81.7 21.7 .90 (-24.66 to 21.86) 
HIV (positive/negative) 4/6 4/6 - 
HCV (positive/negative) 5/5 6/4 - 
Type of hemophilia (A/B) 8/2 10/0 - 
Severity of hemophilia 
(severe/moderate/mild) 
8/1/1 9/0/1 - 
Replacement treatment (prophylaxis/on 
demand) 
8/2 9/1 - 
FVIII dose (IU/Kg) (n = 9 intervention; n = 6 
control) 
27.1 9.4 29.6 13.9 .69 (-10.65 to 15.68) 
FIX dose (IU/Kg) (n = 0 intervention; n = 2 
control) 
48.5 10.5 - - - 
FVIII peak (n = 9 intervention; n = 6 control) 75.8 25.2 53.6 17.3 .049 (-44.39 to -0.08) 
FIX peak (n = 0 intervention; n = 2 control) 47.6 4.7 - - - 
FVIII t1/2 (h) (n = 9 intervention; n = 6 control) 15.8 3.7 12.4 4.3 .10 (-7.65 to 0.69) 
FIX t1/2 (h) (n = 0 intervention; n = 2 control) 28.4 0.2 - - - 
Musculoskeletal data 
    
 
Total knee replacement (yes/no) 0/10 1/9 - 
Total ankle replacement (yes/no) 1/9 0/10 - 
ABJR 1.2 1.2 0.7 0.8 .30 (-1.48 to 0.48) 
HJHS right elbow 4.4 3.6 5.4 6.2 .67 (-3.86 to 5.86) 
HJHS left elbow 2.2 2.9 5.5 5.2 .10 (-0.74 to 7.34) 
HJHS right knee 2.8 4.6 3.6 5.4 .73 (-3.92 to 5.52) 
HJHS left knee 2.4 3.9 3.4 6.1 .67 (-3.79 to 5.79) 
HJHS right ankle 5.9 4.3 4.9 2.7 .54 (-4.40 to 2.40) 
HJHS left ankle 5.3 2.8 5.4 3.9 .95 (-3.07 to 3.27) 
Pettersson right elbow 3.9 3.8 3.7 4.8 .92 (-4.27 to 3.87) 
Pettersson left elbow 2.6 4.1 5.2 5.0 .22 (-1.68 to 6.88) 
Pettersson right knee 1.2 2.4 2.9 4.7 .33 (-1.93 to 5.33) 
Pettersson left knee 2.5 2.8 2.4 4.4 .95 (-3.57 to 3.37) 
Pettersson right ankle 6.1 5.1 3.5 4.7 .25 (-7.21 to 2.01) 
Pettersson left ankle 5.9 5.6 5.2 5.9 .79 (-6.11 to 4.71) 
a
ABJR = annual bleeding joint rate; FIX = factor IX; FVIII = factor VIII; HCV = hepatitis type C virus; HIV = human 
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Table 3. Within-group Change From Baseline to Follow-Up.
a 




  Descriptive Name Mean (95% CI) P
a
 Mean (95% CI) P
a
 
Joint Health (Hemophilia Joint Health 
Score)     
 
Right elbow 0.19 (-1.82 to 2.2) .843 -1.79 (-3.8 to 0.22) .078 
 
Left elbow 0.27 (-0.53 to 1.06) .490 -0.47 (-1.26 to 0.33) .232 
 
Right knee -0.23 (-0.77 to 0.31) .385 -0.27 (-0.81 to 0.27) .308 
 
Left knee 0.67 (0.09 to 1.26) .026 -0.27 (-0.86 to 0.31) .336 
 
Right ankle 0.03 (-1.1 to 1.16) .953 -0.33 (-1.46 to 0.8) .543 
 
Left ankle -0.3 (-1.03 to 0.43) .400 0.4 (-0.33 to 1.13) .266 
 
Total Score  0.99 (-1.97 to 3.95) .490 -2.89 (-5.85 to 0.07) .055 
Isometric muscle strength (Kg) 
    
 
Elbow flexion left -0.61 (-2.76 to 1.54) .558 2.21 (0.06 to 4.36) .045 
 
Elbow flexion right -1.1 (-3.35 to 1.15) .317 2.86 (0.61 to 5.1) .016 
 
Elbow extension left -0.61 (-1.8 to 0.59) .299 1.6 (0.41 to 2.79) .011 
 
Elbow extension right -0.77 (-1.7 to 0.17) .102 1.95 (1.01 to 2.89) .000 
 
Knee extension left -5.62 (-11.85 to 0.6) .074 10.74 (4.52 to 16.97) .002 
 
Knee extension right -5.08 (-10.51 to 0.36) .065 12.72 (7.61 to 17.83) <.0001 
 
Knee flexion left -0.92 (-3.14 to 1.29) .392 5.77 (3.55 to 7.98) <.0001 
 
Knee flexion right -2.05 (-8.13 to 4.04) .487 1.65 (-4.09 to 7.4) .550 
 
Ankle plantarflexion left -8.03 (-20.35 to 4.29) .187 6.92 (-5.4 to 19.23) .253 
 
Ankle plantarflexion right -11.19 (-21.48 to -0.9) .035 3.21 (-7.08 to 13.5) .519 
 
Ankle dorsiflexion left 1.64 (-1.63 to 4.9) .305 5.34 (2.07 to 8.61) .003 
 
Ankle dorsiflexion right 2.73 (-0.56 to 6.02) .098 5.47 (2.17 to 8.76) .003 
Functional capacity (s) 
    
 
Timed Up and Go -0.05 (-0.37 to 0.27) .750 -0.68 (-1 to -0.36) .000 
 
Sit-to-stand -0.25 (-0.67 to 0.18) .238 -1.16 (-1.59 to -0.73) <.0001 
Range Of Motion (°) 
    
 
Knee extension left -3.82 (-8.91 to 1.28) .132 0.32 (-4.78 to 5.41) .897 
 
Knee extension right -0.67 (-1.99 to 0.64) .295 0.47 (-0.84 to 1.79) .458 
 
Knee flexion left -1.39 (-4.56 to 1.77) .366 3.06 (-0.1 to 6.22) .057 
 
Knee flexion right -0.14 (-2.01 to 1.73) .876 3.04 (1.17 to 4.91) .003 
 
Elbow flexion left -1.34 (-5.11 to 2.43) .464 1.37 (-2.4 to 5.14) .453 
 
Elbow flexion right 0.97 (-1.61 to 3.55) .440 4.33 (1.75 to 6.91) .003 
 
Elbow extension left 1.49 (-3.91 to 6.89) .569 3.61 (-1.79 to 9.01) .176 
 
Elbow extension right -2.41 (-5.41 to 0.58) .107 -1.22 (-4.22 to 1.77) .402 
 
Ankle plantarflexion left 2.53 (-1.04 to 6.11) .153 1.93 (-1.64 to 5.51) .269 
 
Ankle plantarflexion right -0.78 (-6.54 to 4.98) .779 0.58 (-5.18 to 6.34) .834 
 
Ankle dorsiflexion left 1.23 (-1.54 to 4) .362 -1.63 (-4.4 to 1.14) .231 
 
Ankle dorsiflexion right 1.69 (-4.75 to 8.13) .587 6.61 (0.17 to 13.05) .045 
Kinesiophobia (Tampa Scale for 
kinesiophobia)     
  Total score -0.4 (-4.07 to 3.28) .823 -1.23 (-5.11 to 2.65) .512 
a
Bold letters denote statistically significant differences. 
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Table 4. Between-group Difference in the Change From Baseline to Follow-Up. 
 
     
  
Descriptive Name 
Control Mean Change 
Minus Intervention 






Minimal Clinically  
Important Differences  
Joint Health (Hemophilia Joint Health Score)     
 
Right elbow 1.98 (-0.87 to 4.84) .161 0.4 1.0 
 
Left elbow 0.73 (-0.43 to 1.9) .203 0.2 0.8 
 
Right knee 0.04 (-0.73 to 0.81) .912 0.0 1.0 
 
Left knee 0.95 (0.12 to 1.77) .027 0.2 1.0 
 
Right ankle 0.36 (-1.24 to 1.97) .638 0.1 0.7 
 
Left ankle -0.7 (-1.73 to 0.34) .173 0.2 0.7 
 
Total Score  3.88 (-0.34 to 8.1) .069 0.2 3.3 
Isometric muscle strength (Kg)     
 
Elbow flexion left -2.82 (-6.14 to 0.5) .091 0.5 1.2 
 
Elbow flexion right -3.95 (-7.18 to -0.73) .019 0.7 1.2 
 
Elbow extension left -2.21 (-3.93 to -0.49) .015 0.4 1.1 
 
Elbow extension right -2.72 (-4.05 to -1.38) .001 0.8 0.7 
 
Knee extension left -16.36 (-25.52 to -7.21) .002 0.8 4.1 
 
Knee extension right -17.8 (-25.93 to -9.67) <.0001 1.2 2.9 
 
Knee flexion left -6.69 (-9.86 to -3.52) <.0001 1.1 1.2 
 
Knee flexion right -3.7 (-12.49 to 5.09) .385 0.4 2.0 
 
Ankle plantarflexion left -14.95 (-32.51 to 2.61) .090 0.5 5.8 
 
Ankle plantarflexion right -14.4 (-28.96 to 0.16) .052 0.4 6.5 
 
Ankle dorsiflexion left -3.7 (-8.44 to 1.04) .118 0.8 0.9 
 
Ankle dorsiflexion right -2.73 (-7.4 to 1.93) .233 0.5 1.1 
Functional capacity (s)     
 
Timed Up and Go 0.63 (0.18 to 1.09) .009 0.5 0.3 
 
Sit-to-stand 0.91 (0.31 to 1.52) .006 0.5 0.4 
Range Of Motion (°)     
 
Knee extension left -4.14 (-11.48 to 3.2) .251 0.7 1.1 
 
Knee extension right -1.15 (-3.01 to 0.72) .212 0.1 2.6 
 
Knee flexion left -4.45 (-9.11 to 0.2) .059 0.4 2.1 
 
Knee flexion right -3.18 (-5.82 to -0.54) .021 0.1 7.1 
 
Elbow flexion left -2.71 (-8.14 to 2.72) .307 0.2 2.4 
 
Elbow flexion right -3.37 (-7.03 to 0.3) .070 0.4 1.9 
 
Elbow extension left -2.13 (-9.8 to 5.54) .566 0.1 4.3 
 
Elbow extension right -1.19 (-5.43 to 3.04) .561 0.1 4.2 
 
Ankle plantarflexion left 0.6 (-4.46 to 5.65) .806 0.0 2.9 
 
Ankle plantarflexion right -1.36 (-9.55 to 6.83) .731 0.1 2.4 
 
Ankle dorsiflexion left 2.86 (-1.13 to 6.85) .149 0.4 1.3 
 
Ankle dorsiflexion right -4.92 (-14.06 to 4.22) .272 0.6 1.7 
Kinesiophobia (Tampa Scale for kinesiophobia)     
  Total score 0.83 (-4.51 to 6.18) .746 0.1 1.6 
a
Bold type denotes statistically significant differences. 
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Table 5. Perceived Changes After the Study (% Subjects). 
      Control Intervention 
Overall pain status 
  Very much improved 20 30 
Much improved 0 40 
Minimally improved 40 30 
No change 40 0 
Minimally worse 0 0 
Much worse 0 0 
Very much worse 0 0 
 Overall health status after the study   
Improved 10 100 
No change 90 0 
Worsened 0 0 
 Desire of practicing exercise 
  
Improved 10 100 
No change 90 0 
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Figure. Intervention training exercises 
1) Knee extension 
2) Knee flexion 
3) Ankle plantarflexion 
4) Ankle dorsal flexion 
5) Elbow flexion 
6) Elbow extension 
7) Shoulder abduction 
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